Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study

References

• McGettigan P , Henry D . Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013;10:e1001388
   PubMed Web of Science ®Google Scholar
• Warner TD , Giuliano F , Vojnovic I , Bukasa A , Mitchell JA , Vane JR . Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999;96:7563–8
   PubMed Web of Science ®Google Scholar
• Van Hecken A , Schwartz JI , Depre M , De Lepeleire I , Dallob A , Tanaka W , et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol 2000;40:1109–20
   PubMed Web of Science ®Google Scholar
• Patrignani P , Tacconelli S , Bruno A , Sostres C , Lanas A . Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert Rev Clin Pharmacol 2011;4:605–21
   PubMedGoogle Scholar
• Giuliano F , Warner TD . Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1999;126:1824–30
   PubMed Web of Science ®Google Scholar
• Gan TJ . Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26:1715–31
   PubMed Web of Science ®Google Scholar
• Lewis SC , Langman MJ , Laporte JR , Matthews JN , Rawlins MD , Wiholm BE . Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002;54:320–6
   PubMed Web of Science ®Google Scholar
• Coxib, traditional NTC . Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769–79
   PubMed Web of Science ®Google Scholar
• Graham DJ , Campen D , Hui R , Spence M , Cheetham C , Levy G , et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475–81
   PubMed Web of Science ®Google Scholar
• McGettigan P , Henry D . Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011;8:e1001098
   PubMed Web of Science ®Google Scholar
• Schmidt M , Christiansen CF , Mehnert F , Rothman KJ , Sorensen HT . Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ 2011;343:d3450
   PubMed Web of Science ®Google Scholar
• Brater DC . Anti-inflammatory agents and renal function. Semin Arthritis Rheum 2002;32:33–42
   PubMed Web of Science ®Google Scholar
• Whelton A . Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13s–24s
   PubMedGoogle Scholar
• Food and Drug Administration . Public health advisory - FDA announces important changes and additional warnings for COX-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). Available from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm150314.htm. Last accessed 7 April 2005
   Google Scholar
• Information ZFP . Iroko Pharmaceuticals, LLC. 2014. Available from: https://www.iroko.com/wp-content/uploads/2014/08/Zorvolex_Approved_PI.pdf; Last accessed 18 February 2015
   Google Scholar
• Gibofsky A , Hochberg MC , Jaros MJ , Young CL . Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Curr Med Res Opin 2014;30:1883–93
   PubMed Web of Science ®Google Scholar
• US Food and Drug administration . International conference on harmonisation; guidelines on the extent of population exposure required to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditons; availability. Fed Regist 1995;60:11270–1
   Google Scholar
• Desjardins PJ , Olugemo K , Solorio D , Young CL . Pharmacokinetic Properties and Tolerability of Low-dose SoluMatrix Diclofenac. Clin Ther 2015;37:448–61
   PubMed Web of Science ®Google Scholar
• World Medical Association declaration of Helsinki . Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925–6
   PubMed Web of Science ®Google Scholar
• Baber N . International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Br J Clin Pharmacol 1994;37:401–4
   PubMed Web of Science ®Google Scholar
• Ware J , Kosinski M , JE D . How to Score Version 2 of the SF–36 Health Survey. Lincoln RI: Quality Metric Inc; 2000
   Google Scholar
• McHorney CA , Ware JE Jr , Raczek AE . The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–63
   PubMed Web of Science ®Google Scholar
• McHorney CA , Ware JE Jr , Lu JF , Sherbourne CD . The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66
   PubMed Web of Science ®Google Scholar
• Hemingway H , Stafford M , Stansfeld S , Shipley M , Marmot M . Is the SF-36 a valid measure of change in population health? Results from the Whitehall II Study. BMJ 1997;315:1273–9
   PubMed Web of Science ®Google Scholar
• Angst F , Aeschlimann A , Steiner W , Stucki G . Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis 2001;60:834–40
   PubMed Web of Science ®Google Scholar
• Brazier JE , Harper R , Munro J , Walters SJ , Snaith ML . Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) 1999;38:870–7
   PubMed Web of Science ®Google Scholar
• Bachmeier CJ , March LM , Cross MJ , Lapsley HM , Tribe KL , Courtenay BG , et al. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthritis Cartilage 2001;9:137–46
   PubMed Web of Science ®Google Scholar
• Strand V , Boers M , Idzerda L , Kirwan JR , Kvien TK , Tugwell PS , et al. It’s good to feel better but it’s better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol 2011;38:1720–7
   PubMed Web of Science ®Google Scholar
• Kiani AN , Strand V , Fang H , Jaranilla J , Petri M . Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 2013;52:1651–7
   PubMed Web of Science ®Google Scholar
• Strand V , Kelman A . Outcome measures in osteoarthritis: randomized controlled trials. Curr Rheumatol Rep 2004;6:20–30
   PubMedGoogle Scholar
• Saag K , van der Heijde D , Fisher C , Samara A , DeTora L , Bolognese J , et al. Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group. Arch Fam Med Nov- 2000;9:1124–34
   PubMedGoogle Scholar
• Strand V , Crawford B , Singh J , Choy E , Smolen JS , Khanna D . Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis 2009;68:1800–4
   PubMed Web of Science ®Google Scholar
• Strand V , Singh JA . Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs 2010;70:121–45
   PubMed Web of Science ®Google Scholar
• Ara R , Brazier J . Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 2008;11:1131–43
   PubMed Web of Science ®Google Scholar
• Ara R , Brazier J . Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health Mar- 2009;12:346–53
   PubMed Web of Science ®Google Scholar
• Curtis SP , Bockow B , Fisher C , Olaleye J , Compton A , Ko AT , et al. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. BMC Musculoskelet Disord 2005;6:58
   PubMed Web of Science ®Google Scholar
• Dahlberg LE , Holme I , Hoye K , Ringertz B . A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Scand J Rheumatol Mar- 2009;38:133–43
   PubMed Web of Science ®Google Scholar
• Dworkin RH , Jensen MP , Gould E , Jones BA , Xiang Q , Galer BS , et al. Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events. J Pain 2011;12:416–24
   PubMed Web of Science ®Google Scholar
• Fleischmann R , Tannenbaum H , Patel NP , Notter M , Sallstig P , Reginster JY . Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis. BMC Musculoskelet Disord 2008;9:32
   PubMed Web of Science ®Google Scholar
• Bueno H , Bardaji A , Patrignani P , Martin-Merino E , Garcia-Rodriguez LA . Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol 2010;105:1102–6
   PubMed Web of Science ®Google Scholar
• Castellsague J , Riera-Guardia N , Calingaert B , Varas-Lorenzo C , Fourrier-Reglat A , Nicotra F , et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf 2012;35:1127–46
   PubMed Web of Science ®Google Scholar
• Chinthapalli K . High dose NSAIDs may double the risk of heart attacks and heart failure, says new study. BMJ 2013;346:f3533
   PubMedGoogle Scholar
• Boelsterli UA . Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002;25:633–48
   PubMed Web of Science ®Google Scholar
• Laine L , Goldkind L , Curtis SP , Connors LG , Yanqiong Z , Cannon CP . How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol 2009;104:356–62
   PubMed Web of Science ®Google Scholar
• Bessone F . Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010;16:5651–61
   PubMed Web of Science ®Google Scholar
• Stubbs B , Hurley M , Smith T . What are the factors that influence physical activity participation in adults with knee and hip osteoarthritis? A systematic review of physical activity correlates. Clin Rehabil 2015;29:80–94
   PubMed Web of Science ®Google Scholar
• Roth SH , Fuller P . Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. J Pain Res 2011;4:159–67
   PubMedGoogle Scholar
• Simon LS , Grierson LM , Naseer Z , Bookman AA , Zev Shainhouse J . Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009;143:238–45
   PubMed Web of Science ®Google Scholar
• Tugwell PS , Wells GA , Shainhouse JZ . Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004;31:2002–12
   PubMed Web of Science ®Google Scholar